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 Marijuana is a popular recreational drug with a  strong following campaigning to legalize it for 
both medicinal and recreational use. This paper serves to illustrate the harmful effects of marijuana use 
as it pertains to prenatal, adolescent and adult use. By understanding the methods of absorption and 
mechanism of interaction in the body, we can see a correlation between the effects of marijuana and its 
toxicity. Through extensive research of case studies on marijuana use we were able to determine 
marijuana’s harmful effects physically, developmentally and cognitively. Through these methods of 
research, it can be concluded that marijuana has detrimental effects on the developing body in utero ,as 
well as, during adolescence. Furthermore, marijuana has consistently been found to cause long term 
damage such as short stature, attention span, and verbal retention (Solowij, et. al. 2011). In adults, 
smoke inhalation of the substance has been found to be more detrimental than the smoke inhalation of 
tobacco.  While marijuana touts a variety of medicinal benefits in its application as a form of palliative 
care, its toxicity and the prolonged adverse effects of the substance are too strong to ignore. 
 
Introduction: 
 Cannabis is one of the first plants to have been used medically, recreationally, and spiritually 
dating back 5000 years, with the first documented medical use in Central Asia and later in China and 
India (Pertwee, 2006). Cannabis is the most widely used illicit recreational drug after the three most 
popular substances, tobacco, alcohol, and caffeine (Green, 1998). Since its discovery, cannabis has been 
used by millions to both induce pleasure and alleviate pain. Physicians have prescribed it for a plethora 
of ailments until the government classified it as a Schedule I substance, rendering it illegal, and without 
medical value. 
 There is a lot of effort being done by the public to try to legalize marijuana with claims that there 
is no basis for the fear and anxiety the public is placing on the drug, and it is in fact a benign substance. 
(NORML, 2013). There are surprisingly limited resources for research done on marijuana, largely due to 
the fact that it is difficult to find subjects willing to cooperate with a study concerning their illegal 
behavior. With over 300 million users worldwide, 28 million of which live in the United States, it is 
important to educate the public about the substance, how to use it safely, and if it exhibits adverse 
effects (Diaz, 1997). 
 The purpose of the research done in this paper is to ascertain the safety or dangers of marijuana, 
focusing on a few aspects to determine if it is in fact harmless. It concentrates on the repercussions of 
prenatal use and its effect on the fetus,its effect on adolescents and determining if there is any 
observable long term damage.  
Method Used: 
The author’s research was done using Touro College’s search engines such as ProQuest, 
CAN MARIJUANA BE HARMFUL? 
	  
2 
MEDLINE, and EBSCO, as well as research articles found through PubMed and Google Scholar. The 
method of research included reviewing studies and published articles that have been peer reviewed. In 
certain cases the author questioned the validity and accuracy of the methods used to attain the data 
presented and documented their uncertainty of the method of research. In other cases the author 
presented conflicting arguments to refute some peer reviewed studies to present that not all studies can 
be accepted at face value. 
 
Marijuana Intake and Potency: 
Cannabis, colloquially known as marijuana, is a recreational drug whose leaves, flowers, and 
stems are all utilized in its use. The chemical compounds found within the Marijuana plant identify it as 
a member of the cannabinoid class. The cannabinoid plant, whose scientific name is Cannabis sativa, 
has a distinctive smell that is similar to that of skunk musk. The described effects of marijuana are 
relaxing, calming, mellowing, and sometimes anxiety and paranoia provoking. Collectively, these 
effects are referred to as a ‘high.’ (Sharman, et. al. 2013). 
 The predominant psychoactive component in marijuana that determines its potency is 
delta-9-tetrahydrocannabinol, or THC, and was only isolated in 1964. This molecule is the chemical 
stimulant in the Cannabis plant that produces the altered states of consciousness in the user. 
 THC actually exists as Tetrahydrocannabinolic acid, THCA, in the Cannabis plant and is the 
biosynthetic precursor of THC. Conversion of THCA to THC occurs through burning of the plant. 
Combustion causes decarboxylation to occur on the THCA converting it to the more psychoactive THC 
molecule (Hazekamp, et. al. 2005). The depth or strength of the psychoactive component of the cannabis 
is highly dependent upon the growing conditions and the genetic strain of the plants (Copeland, et. al. 
2006). 
 There are a variety of common methods for marijuana intake. These include but are not limited to 
smoking the dried leaf of the plant in a the form of a rolled cigarette or “joint”, using a water pipe or 
“bong” to inhale the fumes, consumption in food, inhalation of vapors through a vaporizer, and ingestion 
of the plants oils. Smoking is the most common and preferred route of intake but it is dulled by the fact 
that only 5-14% of the smoke is actually THC, and 30-80% of the smoke in the “joint” is lost to escaped 
smoke (Copeland, et. al. 2006). 
 Smoking in itself is a dangerous method of intake as it is harmful to the lungs and respiratory 
system. Marijuana smokers are subject to the same dangers and health risks as tobacco smokers with 
similar negative results such as respiratory distress, asthma, cardiovascular disease, lung and esophageal 
cancers (Ellenhorn, Barceloux, 1988).  
 The second method of choice involves using a water pipe commonly known as a “bong”. The 
bong minimizes the THC lost in the smoke because it is all contained within the bowl and then 
effectively inhaled. This method can be dangerous due to the larger amounts of carbon monoxide and tar 
inhaled. Smoking hashish, which is the resin from the plant smoked in a pipe, is less common but is 
done by adding a few drops of oil to tobacco or cannabis leaves and smoking it in a joint. Another 
alternative is heating the oils and inhaling the vapors. The oil can also be incorporated in food and 





 Newer methods, such as the use of vaporizers, have been utilized and have less harmful effects. 
These machines heat the cannabis and trap the tar and toxins in a special chamber allowing only the 
THC to be inhaled without the added harmful smoke. This is a useful method for patients who are using 
marijuana to aid in palliative care and treat illnesses. Through this method they are able to maximize the 
benefits of marijuana use without risking further damage to their health. Inhalers are also available for 
oral doses of THC, once again created for the purpose of medical palliative care (Martin, Wiley, 2004). 
 
Chemical Pathways of THC: 
 THC is an extremely potent chemical and takes only a matter of seconds to enter your bloodstream 
and reach your brain. When smoked, it takes effect almost immediately and can last anywhere from 1-3 
hours. When consumed in food there is a delayed onset of the desired effect, but the THC stays in your 
system for a longer period of time. Though the full mechanisms of THC still remain unknown, 
neuroscientists have some information about its effects on the brain  (Diaz, 1997). 
 To understand how THC is interacts with the brain’s cells, we must first understand the 
mechanisms that the brain uses to communicate. Neurons are the cells of the brain that transmit 
information. Neurons interact with each other through a chemical messenger system known as 
neurotransmitters. Neurotransmitters attach to protein structures imbedded in the membrane of the 
receiving neuron known as receptors. The attachment of neurotransmitters to these receptors facilitates 
the transmission of important information from one cell to the other. Each neuron has thousands of 
receptors and each receptor is specific to a certain neurotransmitter (Diaz, 1997). 
  THC is a cannabinoid and is therefore able to mimic endogenous cannabinoid neurotransmitters, 
such as N-arachidonoylethanolamine (anandamide) or 2-arachidonoyl glycerol. The discovery of these 
endocannabinoids in 1992 by Israeli scientist Raphael Mechoulam emerged from a study in which he 
was trying to determine the purpose of cannabinoid receptors in the body (Devane, et. al. 1992).  It was 
discovered that these endocannabinoid neurotransmitters are released by the body into the brain when 
the body senses an elevation in intracellular calcium. The THC binds to the cannabinoid receptors in 
place of the anandamide and therefore activates the appropriate neurons that would alternately be 
activated by anandamide (Sharman, et. al. 2013). THC exerts a majority of its influence through the 
midbrain reward center, triggering dopamine release in the prefrontal cortex which causes marijuana to 
have an addictive quality (Kogan, Mechoulam, 2007). 
 The presence of THC in the brain interferes with the neurons’ normal function by artificially 
stimulating the cannabinoid receptors. Certain portions of the brain have concentrated cannabinoid 
receptors while others contain only a small number. These receptors can be found in areas of the brain 
including; the cerebellum, hippocampus and basal ganglia, areas that influence pleasure, 
memory,  concentration, sensory and time perception, as well as coordinated movement. Therefore, 
THC can affect the sensations associated with thefunctions of these regions of the brain in which the 
cannabinoid receptors are found, resulting in the sensation of being ‘high’ (Devane, et. al. 1992). 
 The largest portion of the cannabinoid receptors are found in the hippocampus which is located in 
the medial temporal lobe, beneath the cortical surface of the brain and is associated with short term 
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memory. THC therefore, has the greatest effect on that portion of the brain, explaining why users 
typically report having trouble with short term memory. The cerebellum and basal ganglia have many 
cannabinoid receptors as well and therefore those under the influence of THC also report problems with 
coordination and muscle movements (Sharman, et. al. 2013). 
 There are two types of cannabinoid receptors identified as CB1 and CB2, in order of their 
discovery. These receptors act through inhibiting adenylate cyclase. The CB1 receptors are primarily 
found in the central nervous system, brain and nerve tissue, specifically the basal ganglia, hippocampus, 
cerebellum, and cerebral cortex, as well as, on the peripheral neurons. Their main function is to mediate 
inhibition of on-going release of certain excitatory and inhibitory neurotransmitters. CB2 is found in non 
neuronal cells in immune system tissues such as leukocytes, the spleen, and bone marrow, and was first 
discovered in human leukemia (Green, 1998). 
 
Marijuana Toxicity: 
 An important factor to consider is the toxicity level of marijuana. In comparison with regular 
tobacco smokers, marijuana smoke creates a greater cardiovascular burden due to the high levels of 
carbon monoxide and tar found in cannabis resulting in a heavy respiratory burden on the smoker. 
 Marijuana smokers are also known to take larger, deeper puffs and hold the smoke in their lungs 
for a longer period of time. Because of this practice, the retention of  tar in the respiratory tract is one 
third greater than the amount of tar built up from tobacco smoke. Additionally, smoking marijuana 
results in much higher level of carboxyhemoglobin than its counterpart, tobacco. Regardless of the THC 
content, the smoking of cannabis in itself yields a higher carbon monoxide and tar weight on the 
respiratory tract (Wu, et. al. 1988). 
 Marijuana has also been found to exacerbate psychotic illnesses in susceptible users, particularly 
schizophrenia. After testing the correlation between THC and psychosis, marijuana was found to cause 
consequent anxiety and neuropsychological impairment in users. THC can induce a transient, acute 
psychotic reactions in psychiatrically well individuals (Rais, et. al. 2008; Barch, Smith, 2008). 
Minutes after a dose of THC is delivered in an individual there are notable deficits in working 
memory and executive functions with a trend towards an impaired episodic memory. This is significant 
as it is well established that schizophrenia is associated with deficits in those functions (Rais, et. al. 
2008; Barch, Smith, 2008). Although the data is telling, the properties of THC are highly dose 
dependent with a possibility for bidirectional effects. There is also not much explanation of why some 
individuals are more susceptible to psychotic symptoms than others. 
 Marijuana is absorbed in the bloodstream from the lungs within minutes of inhalation generating 
an extremely immediate reaction in the body with the swift onset of a ‘high.’ The degree of intensity of 
the high depends on the quality of the cannabis, the method of use, and the experience of the user. 
Familiarity is a factor because a more experienced user will know how to maximize the inhalation, but 
also may be immune and therefore unaffected by some of the THC absorbed (Copeland, et. al. 2006). 
Immunity occurs when the body is chemically altered and builds a certain level of tolerance to the 
presence of marijuana thus requiring a higher dose to attain identical results from the previous use. The 




degree of high, while compromising his body and health. While the THC carries out it psychoactive 
effects, it is simultaneously harming the body’s cardiovascular system by lowering blood pressure and 
increasing heart rate: a potential danger for chronic marijuana users (Gorelick, et. al. 2013). 
 
Marijuana and Fetal Development:  
 To further understand the toxicity level and dangers of the substance, we must observe its effects 
on a developing fetus. Studies have been conducted that test the neurodegenerative effect of cannabis 
exposure on a developing rodent’s brain. Tests like these help scientists build a parallel analysis on the 
effects of cannabis in human neonatal development.   
 Because of the differences in human and rodent development, analyses were done on a seven day 
old rodent which is most similar to a third trimester fetus. Perhaps the most obvious limitations to this 
study is that testing was done exclusively on rats rather than relying on information gathered from actual 
human case studies and assessing the available neurodegenerative data. Furthermore, the fact that the 
rodent was not in utero during testing raises questions as to the environmental differences in the 
conditions of the third trimester of a human fetus. One might argue that there is a level of neonatal 
protection when a child is in the womb, and that could protect it from foreign toxins as opposed to a 
rodent pup that has to fend for itself. There can also be claims that a child in utero may be exposed to 
more toxins due to the direct stream of oxygen and nutrition passed from the mother, therefore exposing 
the fetus to greater risk when its body is still vulnerable and reliant on maternal nutrients rather than 
depending on its own immune response. 
 There is evidence, however, supporting the research done on rodents by studying the effects of 
marijuana on a fetus during the second trimester. Smoking of marijuana was found to have a significant 
effect on the stature of the unborn child. There is an additional increased risk of premature birth, stunted 
growth, and morbidity if the offspring is that of an adolescent even if their levels of drug use are lower 
than those of adult pregnant women (Cornelius, et. al. 2002).  
 Further evidence can be found in preschool children who were assessed for sustained attention 
after fetal exposure to marijuana. In these studies, children were found to have various levels of 
decreased sustained attention. Although this implies that marijuana can have an adverse direct effect on 
the fetus, the fact that these mothers were users of other drugs including alcohol and tobacco, 
complicates analysis. Therefore, although there is conclusive data linking marijuana to these results, it is 
difficult to isolate which substance was the precise cause of the inattentiveness (Fried, et. al. 1992).  
 With an increase of admitted dose of marijuana use, however, there was a correlated increase in 
the failure of the exposed children to maintain vigilance and sustain information appropriate to their 
grade level. There is also a greater likelihood of omission errors, indicating a lack of attention and a 
described impulsivity and hyperactivity that grew with increasing prenatal dose exposure (Noland, et. al. 
2005). These effects were predominantly exhibited in preschool aged children as altered inattentive 
behavior and if exposed to these drugs at a young age, they also exhibit greater trouble with behavior 
and focusing, 
 Double blinded studies such as these are well assessed and dependable due to the fact that the 
testers are not aware of the substance exposure status of the children and therefore minimizing biased 
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answers or observations. There are limitations as noted previously as many of the mothers of the 
children tested were exposed to various drugs as well. This limits the scope of observation and obscures 
our view as to which of the substances were the cause of the inattentiveness. (Richardson, et. al. 2002). 
 Experiments on pregnant mammals have shown adverse effects and though the results have been 
quite supportive of the data, it remains difficult to predict how similar levels of THC would affect 
pregnant humans. One aspect that has been neglected by these studies is the adverse effect that smoke 
inhalation may have on the child. Although THC in itself is proven to be detrimental to the fetus, there is 
an added risk when marijuana is smoked, which is usually the case since that is the most common form 
of intake. Although there are some human studies revealing the effects on a fetus, there is limited data 
available due to the shortage of people willing to be included in a study (Jutras-Aswad, et. al. 2009). 
 Clearly, marijuana use and exposure during pregnancy is extremely harmful to the unborn 
child. THC is especially dangerous due to the ease in which it is able to cross the placental barrier, 
therefore entering the fetus’s blood supply where it could cause adverse effects. The THC builds up in 
the fat and liver tissue of the mother and is then passed through the placental barrier. The levels of THC 
present can be easily measured in the amniotic fluid, with stronger concentrations yielding more harmful 
results. The speed of transfer is essential because it enables the drug to achieve its pharmacological 
effects once it comes in contact with the fetus. Consequently, injection of THC during early pregnancy 
in rodents produced a seventy percent feticide (Harbison, Mantilla-Plata, 1972).  
Additionally, negative effects of the marijuana are also observed if the fetus survives. Once 
the child develops, they can exhibit; an altered response to visual stimuli, increased tremulousness, 
problems with sustained attention and memory, and poor problem-solving skills (Diaz, 1997).  
 
Adolescent Use: 
  The number of teenagers informed of the harmful effects of marijuana is decreasing, and 
consequently there is an increase in adolescent daily marijuana smokers. Marijuana can have an effect 
on the brain for users who began to smoke during adolescence, as opposed to adulthood. This creates a 
noticeable decline in IQ from the point of adolescence to adulthood. Through standardized IQ testing it 
was determined that there was an average of an eight point decline of IQ by mid age. There is a 
significant impairment of cognitive function, specifically related to attention and memory, and there is 
an increasing vulnerability to psychosis. There is no proof that stopping use of marijuana will improve 
cognitive function, and the effects of persistent cannabis remain, causing a neuropsychological decline. 
Many teenagers and even clinicians are not aware of the high probability of intellectual or 
psychopathological impairment due to the neurotoxic effects of THC (Meier, et. al. 2012). 
 Long term cannabis use is specifically detrimental to the white matter of the brain in adolescence 
and early adulthood. Magnetic Resonance Imaging devices make it easy to determine the portion of an 
individual’s white matter that has been affected. Heavy cannabis use affects axonal connectivity and 
impairs fimbria of the hippocampus. This is due to the many cannabinoid receptors present in the 
developing white matter of the brain in fibre pathways (Zalesky, et. al. 2012). The age of 
commencement of use of cannabis is crucial in determining its effect on white matter, the earlier the 




a link between long term marijuana use and the onset of schizophrenia as discussed previously (Rais, et. 
al. 2008). 
 Overall, cannabis use is more detrimental to the cognitive effects of a growing adolescent than in 
adults. Unfortunately, marijuana has always been linked to younger users, where it has the greater effect 
on the subject’s cognitive function. Even more so, smaller doses of marijuana pose a greater risk to the 
developing brain than larger doses will have on a fully developed adult brain. (Solowij, et. al. 2011) 
 Tested at differing intervals of exposure; before use, during, and after, cannabis users are found to 
be more anxious, more susceptible to depression, and have lower cognitive abilities than their 
counterparts. Those that used marijuana consistently have lower verbal learning and memory scores than 
even alcohol users and control groups alike. There is also impaired retention, storage, and retrieval in 
cannabis users. Cannabis at low doses in adolescents is still proven to be destructive. The earlier the use 
of cannabis, and the more frequent, the greater the damage associated with the brain even once cannabis 
use has ceased (Solowij, et. al. 2011). A convincing amount of data builds a strong correlation between 
the use of marijuana and impaired cognition.  This demonstrates that even in low doses, cannabis can 
impair the memory of young adults (Reynolds, Parfit, 1993). 
Debate: 
 In a 1992 study, information was published concerning marijuana safety. The scientists, Nahas and 
Latour, (1992) concluded that extended marijuana use caused prolonged impairment of psychomotor 
performance; impairment of memory in adolescents; cancer of mouth and jaw; fetotoxicity; an increase 
in the incidence of schizophrenia; and leukemia in children of marijuana smoking mothers.  
 Soon after reviewing the information presented, further research was conducted to determine its 
accuracy. Regrettably, the additional investigation into the study confirmed that eighty percent of the 
citations were inaccurate and numerous others were misrepresented or biasedly reported. Hence, it is 
certainly necessary to inquire further whenever new research material is presented, and to be aware of 
possible discrepancies in any form of research (Macdonald, Gregory, 1994). This of course does not 
discredit all the research presented, but advises the reader to always verify sources and inquire further. 
 Another instance of contradictory studies is a 2003 analysis stating that cannabis use was found to 
cause impairment in both cognitive function and mood (Klugman, Gruzelier, 2003). A later review in 
2006, however, noted that workers reported that they performed equally well in controls, working 
memory, and selective attention tasks as their counterparts (Wadsworth, et. al. 2006).  
 In addition to possible discrepancies with research studies, there are other possible perspectives on 
marijuana. While the effects of smoking marijuana itself can be harmful to the health of an individual, 
and by all accounts it is extremely toxic in young adults as well as fetuses, it is not considered a highly 
toxic substance. Marijuana is unique in that it has an extremely high lethal dose. Meaning, an individual 
would have to consume 40,000 times the usual dose to trigger a lethal response. Equal amounts of 
caffeine would lead to death quicker than marijuana. As of yet there are no documented cases 
implicating marijuana as the cause of death (Annas, 1997).  
Recent interest has fueled progress in development of medicinal drugs. One such drug can be 
used topically to introduce the lipophilic substance into the body by using micro-emulsions and 
cyclodextrins to create greater solubility in aqueous solutions. This new form of application could result 
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in a less harmful method to utilize the beneficial medicinal properties of marijuana. (Green, 1998). 
 In addition, new forms of use can enable patients suffering from life threatening illnesses with 
symptoms that compromise their health and quality of life a way to control the pain. The discovery of 
the endocannabinoid system has led to an interest in the production of cannabinoid medications for 
treatment of symptoms such as nausea, vomiting, weight loss, and pain relief. Some of these 
synthetically produced cannabinoid medications have already been FDA approved which could prove to 
significantly enhance the quality of life for a patient suffering from an illness (Martin, Wiley, 2004).  
 While marijuana may have therapeutic benefits, a majority of the research conducted is on real 
users of the substance. This is a drawback because the dosage of THC in their systems are too high to 
properly assess what the outcome would be if the doses were administered and regulated. Even though 
there is promise in the study for the drug to be used medically, not enough case studies have been 
performed as of yet to examine all the parameters of the drug (Zuurman, et. al. 2009).  
 
Conclusion: 
 Educated by the media and influenced by current social cultures, the author initially began this 
research project with the impression that marijuana was a benign and harmless substance. After doing 
extensive research on the subject, and reading a wealth of information, the author’s views have been 
dramatically transformed. 
The data concerning prenatal use as well as adolescent abuse of marijuana have proved to be 
quite conclusive with evidence demonstrating the harmful effects of the substance. There is a 
considerable amount of information available detailing a plethora of study methods and techniques 
which all yield similar adverse results. Although there seems to be promising research regarding 
marijuana as a medicinal therapeutic drug, as of now it is a very new and undeveloped method of 
treatment with lack of adequate information to ensure its long term safety. 
 While there is still a lot more research to be done, the information gathered concerning 
marijuana’s adverse effects are too strong to ignore.  
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